Fisiopatologici e Clinici

Size: px
Start display at page:

Download "Fisiopatologici e Clinici"

Transcription

1 18 Simposio annuale ELAS-LIGAND LIGAND ASSAY 2012 LE MALATTIE INFIAMMATORIE INTESTINALI Aspetti Fisiopatologici e Clinici Giovanni Maconi Cattedra di Gastroenterologia Dipartimento di Scienze Biomediche e Cliniche Polo Universitario Luigi Sacco Università di Milano

2 Inflammatory bowel diseases Ulcerative colitis Crohn s disease Idiopathic, Collagenous lifelong, chronic colitis intestinal Lymphocitic colitis conditions characterized by Ischaemic colitis Diversion colitis periods of REMISSION Bechet disease and Indeterminate recurrent RELAPSES. colitis

3 Inflammatory bowel diseases Epidemiology Clinical features Natural history Behaviour Extension Treatment strategies Pathogenesis

4 Inflammatory bowel diseases Epidemiology Clinical features Natural history Behaviour Extension Treatment strategies Pathogenesis

5 Incidence and Prevalence of IBD Systematic review Ulcerative colitis Crohn s disease Incidence (per 100,000 person-years) Europe North thamerica Asia and Middle East Prevalence (per 100,000 persons) Europe North America Molodecky et al. Gastroenterology 2012

6 Incidence and Prevalence of IBD Systematic review Ulcerative Crohn s disease Colitis Molodecky et al. Gastroenterology 2012

7 Inflammatory bowel diseases Epidemiology Clinical features Natural history Behaviour Extension Treatment strategies Pathogenesis

8 Inflammatory bowel diseases Clinical Features Clinical indexes Endoscopic indexes Biochemical indexes

9 Ulcerative colitis Clinical Features SEVERITA Attività clinica - Influenza il tipo di terapia (orale, topica, parenterale, chirurgica) - Remissione = < 3 scariche / die, senza sangue con mucosa normale Remissione Lieve Moderata Severa N. scariche Asintomatico 4 > Sangue Può esserci Presente Presente o Polso (bmp) Normale Segni minimi > 90 bpm o Temperatura Normale di tossicità ità > o Emoglobina Normale sistemica <10.5 g/dl o VES Normale > 30 mm/h Classificazione di Montreal dell attività clinica nella colite ulcerosa

10 Ulcerative colitis Endoscopic Features SEVERITA Attività endoscopica Scores endoscopici di attività (Baron et al., Schroder et al. Feagan et al.) Parametri endosopici: Edema, eritema, granularità, sanguinamento, erosioni, ulcere

11 Ulcerative colitis Clinical Features Mayo score SEVERITA Attività clinica ed endoscopica Remissione 0 Lieve 1 n. Scariche Normale 1-2 / die > normale Moderata / die > normale Severa 3 5 / die > normale Sangue No Tracce Evidente Abbondante Mucosa Normale Lieve friabilità Moderata friabilità Sanguinam. Spontaneo Condizioni generali Normale Lieve Moderato Severo Classificazione di Mayo dell attività clinica ed endosopica nella colite ulcerosa

12 Crohn s disease Clinical Features Crohn s Disease Activity it Index (Best) SEVERITA Attività clinica Clinical or laboratory variable Weighting g factor Number of liquid or soft stools each day for seven days x 2 Abdominal pain (graded from 0-3 on severity) each day for seven days x5 General well being, subjectively assessed from 0 (well) to 4 (terrible) each day for seven days Presence of complications * x20 Taking Loperamide or opiates for diarrhea x 30 Presence of an abdominal mass (0 as none, 2 as questionable, 5 as definite) x 10 Hematocrit of <0.47 in men and <0.42 in women x 6 Percentage deviation from standard weight x 1 x 7 Severe Active Remission disease >150 <150 >450

13 Crohn s disease and Ulcerative colitis Clinical Features - Complications Hepatobiliary Muscoloskeletal Dermatologic Ocular Genitourinary i Vascular and hematologic Cardiac Pulmonary Endocrine and metabolic Most common triad Anal fissures, fistulae or abscesses, or other fistulae Fever during previous week

14 Inflammatory bowel diseases Epidemiology Clinical features Natural history Behaviour Extension Treatment strategies Pathogenesis

15 Ulcerative colitis Clinical course during 5 years of follow up 59% 1% 9% 31% 420 patients Henriksen et al. IBD 2006

16 Ulcerative colitis Clinical course during 25 years of follow up remission i intermittent i activity i continuous activity i 100% 90% 80% 70% 60% 50% 40% 30% 20% 10 % 0% M onths after diagnosis Langholz E et al. Gastroenterology 1994

17 Crohn s disease Clinical course during 10 years of follow up 43% 3% 19% 32% 197 patients Solberg C et al. CGH 2007

18 Crohn s disease Clinical course during 25 years of follow up 100% 90% 80% 70% 60% 50% 40% 30% 20% 10 % 0% High activity Low activity Remission years from diagnosis 373 patients Copenhagen Munkholm P et al. Scand J Gastroenterol 1995

19 Crohn s disease Natural history Symptoms Complications Lesions Surgery

20 Crohn s disease Natural history Behaviour over time inflammatory stenosant penetrating Louis E et al. Gut 2001

21 Crohn s disease Natural history Behaviour over time Cosnes Acta Gastroenterol Belg 2008

22 Crohn s disease Natural history Strictures and Fistulae Stenosi Fistola Ulcere profonde Riepitelizzazione

23 Crohn s disease Natural history Cumulative surgery rate ±2 SD Probabilit ty % Years Munkholm et al. Gastroenterology 1993

24 Crohn s disease Natural history Number of operations Years after diagnosis 1 surgery 2 surgery >3surgery No surgery 5 37 % 7% 5% 51 % % 11 % 12 % 39 % % 14 % 22 % 30 % Munkholm P et al. Gastroenterology 1983

25 Crohn s disease Natural history Use of immunosuppressant and Surgery rate Cosnes J et al. Gut 2005

26 Crohn s disease Natural history Recurrence and symptoms after operation Rutgeerts P. et al. Gastroenterology 1990

27 Inflammatory bowel diseases Treatment Conventional approach INDUCTION OF REMISSION Infliximab? Other biologics? MAINTAINANCE OF REMISSION Infliximab? Other biologics? CyA 6MP/AZA Corticosteroids 5-ASA/SASP severe moderate mild 6MP/AZA 5-ASA/SASP

28 Inflammatory bowel diseases Treatment Reversing the therapeutic pyramid? Early Biologics Steroids AZA / 6-MP / MTX Surgery Late 5-ASA +/- Antibiotics

29 Inflammatory bowel diseases Epidemiology Clinical features Natural history Behaviour Extension Treatment strategies Pathogenesis

30 Inflammatory Bowel Diseases Disease extension Ulcerative colitis Crohn s disease

31 Inflammatory Bowel Diseases Disease extension a dynamic state Influence on: Therapeutic and monitoring i approach Disease complications Delayed time to diagnosis from symptoms onset Cancer risk and timing of surveillance programs

32 Ulcerative Colitis Disease extension - Progression Extent at diagnosis Extent at follow-up Proctitis Left-sided colitis Pancolitis Pancolitis 34,0 % 70,4 % 98,3 % Lef-sided colitis 11,9 % 25,7 % 0,8 % Proctitis 54,1 % 3,9 % 0,8 % 1116 Cleveland pts Farmer RG et al. Dig Dis Sci 1993

33 Ulcerative Colitis Disease extension - Risk Factors of Progression Distal colitis Colitis with progression Extraintestinal manifestations 15.5% 5% 42.9% Steroid-refractory course 2.2% 28.0% Requirement of thiopurines 17.3% 44.3% Cyclosporine 1.9% 25.4% Infliximab 1.2% 9.5% Surgery 0.6% 20.6% Neoplasia 0% 6.3% 420 UC patients Etchevers M et al. IBD 2009

34 Ulcerative Colitis Disease extension and Cancer Risk Extensive colitis Left-sided colitis Cumula ative risk % Years

35 Crohn s disease Disease extension over time ileal colonic ileocolonic upper Louis E et al. Gut 2001

36 Crohn s disease Disease extension and cancer Site Relative risk 95% CI Ileal 1,0 0,1-3,4 Ileocolonic 32 3, ,7-9,2 Colonic 5,6 2,1-12,2 Other 1,2 1,3-4,3 Total 2,5 1,3-4,3 Ekbom et al. Lancet 1990

37 Inflammatory bowel diseases Pathogenesis Why?

38 Inflammatory bowel diseases Pathogenesis Genetics NOD2 Crohn s disease

39 Inflammatory bowel diseases Pathogenesis Immunity

40

41 Immune system in IBD

42 Inflammatory bowel diseases Biochemical, molecular and fecal biomarkers Challenges in IBD Diagnosis Differential diagnosis Assessment of disease activity Assessment of risk of complications Prediction of relapse Monitoring the effect of therapy

Evidence of Crohn s Disease. Case Presentation

Evidence of Crohn s Disease. Case Presentation Witt Wait to Treat tutiled Until Endoscopic Evidence of Crohn s Disease Raymond Cross, MD, MS, AGAF Associate Professor of Medicine Director, IBD Program University of Maryland School of Medicine Co-Director,

More information

GET THE GUTSY TRUTH ABOUT INFLAMMATORY BOWEL DISEASE EXPECT MORE FROM YOUR TREATMENT

GET THE GUTSY TRUTH ABOUT INFLAMMATORY BOWEL DISEASE EXPECT MORE FROM YOUR TREATMENT GET THE GUTSY TRUTH ABOUT INFLAMMATORY BOWEL DISEASE EXPECT MORE FROM YOUR TREATMENT Patient Education Forums - KOL Presentation What We Will Discuss Today Understanding Inflammatory Bowel Disease (IBD)

More information

Background information

Background information Background information Inflammatory bowel disease Inflammatory bowel disease (IBD) encompasses a group of long-term disorders, including ulcerative colitis (UC) and Crohn s disease, which produce inflammation

More information

Endoscopy is an important diagnostic and therapeutic

Endoscopy is an important diagnostic and therapeutic ORIGINAL ARTICLE Appropriateness and Diagnostic Yield of Colonoscopy in the Management of Patients with Ulcerative Colitis: A Prospective Study in an Open Access Endoscopy Service Gianpiero Manes, MD,

More information

Terapia con farmaci biologici e non nella. Sandro Ardizzone. Azienda Ospedaliera Fatebenefratelli e. Ospedale di Rilievo Nazionale Milan

Terapia con farmaci biologici e non nella. Sandro Ardizzone. Azienda Ospedaliera Fatebenefratelli e. Ospedale di Rilievo Nazionale Milan Terapia con farmaci biologici e non nella Colite Ulcerosa Severa/Refrattaria Sandro Ardizzone Gastrointestinal Unit Azienda Ospedaliera Fatebenefratelli e Oftalmico Ospedale di Rilievo Nazionale Milan

More information

CHAPTER 1. Inflammatory bowel disease

CHAPTER 1. Inflammatory bowel disease CHAPTER 1 Inflammatory bowel disease Inflammatory bowel disease refers to two chronic diseases that cause inflammation of the intestines: ulcerative colitis and Crohn's disease. Although the diseases have

More information

TREATING INFLAMMATORY BOWEL DISEASE (IBD) BACKGROUNDER

TREATING INFLAMMATORY BOWEL DISEASE (IBD) BACKGROUNDER Press information for journalists only TREATING INFLAMMATORY BOWEL DISEASE (IBD) BACKGROUNDER Why treat IBD? IBD describes a range of chronic diseases of the gastrointestinal system, encompassing Ulcerative

More information

EVIDENCE BASED TREATMENT OF CROHN S DISEASE. Dr E Ndabaneze

EVIDENCE BASED TREATMENT OF CROHN S DISEASE. Dr E Ndabaneze EVIDENCE BASED TREATMENT OF CROHN S DISEASE Dr E Ndabaneze PLAN 1. Case presentation 2. Topic on Evidence based Treatment of Crohn s disease - Introduction pathology aetiology - Treatment - concept of

More information

Inflammatory Bowel Disease Fatigue. Sinead Nolan Gastroenterology CNS Bon Secours Hospital

Inflammatory Bowel Disease Fatigue. Sinead Nolan Gastroenterology CNS Bon Secours Hospital Inflammatory Bowel Disease Fatigue Sinead Nolan Gastroenterology CNS Bon Secours Hospital Inflammatory Bowel Disease Ulcerative colitis Crohns Disease Indeterminate colitis Microscopic colitis Etiology

More information

Top Down vs. Step Up Therapy Biologics in IBD: Treatment Algorithms. Stephen B. Hanauer, M.D. University of Chicago

Top Down vs. Step Up Therapy Biologics in IBD: Treatment Algorithms. Stephen B. Hanauer, M.D. University of Chicago Top Down vs. Step Up Therapy Biologics in IBD: Treatment Algorithms Stephen B. Hanauer, M.D. University of Chicago Treatment Goals c.2008 Induce and maintain response/remission Prevent complications Disease

More information

9/6/2014 IBD TREATMENT: TARGETS FOR THE MODERN AGE OBJECTIVES TREAT TO TARGET: WHAT DO WE MEAN?

9/6/2014 IBD TREATMENT: TARGETS FOR THE MODERN AGE OBJECTIVES TREAT TO TARGET: WHAT DO WE MEAN? IBD TREATMENT: TARGETS FOR THE MODERN AGE ERIC BENCHIMOL, MD, PhD, FRCPC CHEO Inflammatory Bowel Disease Centre Division of Gastroenterology, Hepatology and Nutrition Children s Hospital of Eastern Ontario

More information

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, M.D. Cleveland Clinic Foundation Cleveland, OH

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, M.D. Cleveland Clinic Foundation Cleveland, OH INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, M.D. Cleveland Clinic Foundation Cleveland, OH 1. What is inflammatory bowel disease? Inflammatory bowel disease (IBD) refers to two related but different diseases:

More information

Inflammatory Bowel Disease

Inflammatory Bowel Disease Inflammatory Bowel Disease Digestive problems are among the most common conditions affecting Americans today. There are many different types of digestive problems, from gastrointestinal infections that

More information

Biomarkers in Inflammatory Bowel Disease

Biomarkers in Inflammatory Bowel Disease Biomarkers in Inflammatory Bowel Disease DR. MAHMOUD MOSLI MD FRCPC ABIM MSC (CLINICAL EPIDEMIOLOGY AND BIOSTATISTICS) ASSISTANT PROFESSOR, KING ABDULAZIZ UNIVERSITY Introduction The diagnosis of Inflammatory

More information

Understanding Colitis and Crohn s Disease

Understanding Colitis and Crohn s Disease Improving life for people affected by Colitis and Crohn s Disease Understanding Colitis and Crohn s Disease 1 Understanding Colitis and Crohn s Disease Understanding Ulcerative Colitis and Crohn s Disease...

More information

Inflammatory Bowel Disease (IBD) Outline. Outline. Management & Treatment

Inflammatory Bowel Disease (IBD) Outline. Outline. Management & Treatment Inflammatory Bowel Disease (IBD) Management & Treatment Gregory Austin, MD MPH Assistant Professor of Medicine Division of Gastroenterology & Hepatology University of Colorado Denver Outline Case: 23yo

More information

Inflammatory Bowel Disease

Inflammatory Bowel Disease Inflammatory Bowel Disease Prolonged Remission With Supplements and Diet by Kelly Brown, BSc, ND Clinic One 286 McDermot Avenue Winnipeg, Manitoba R3B 1H6 204 957 5300 www.clinic-1.com Inflammatory bowel

More information

11/10/2014. New Treatments in IBD: When, Whom and How. Background. Background. Options. Disease Assessment. What is the evidence?

11/10/2014. New Treatments in IBD: When, Whom and How. Background. Background. Options. Disease Assessment. What is the evidence? New Treatments in IBD: When, Whom and How. Background Options Disease Assessment What is the evidence? Kofi Clarke MD, FACP,FRCP (Lond) Clinical Associate Professor, Chief, Gastroenterology, Hepatology

More information

understanding IBD INFLAMMATORY BOWEL DISEASE A patient s guide from your doctor and

understanding IBD INFLAMMATORY BOWEL DISEASE A patient s guide from your doctor and understanding IBD INFLAMMATORY BOWEL DISEASE A patient s guide from your doctor and To help you understand and manage your condition, the AGA Institute provides you with the following information, designed

More information

Ulcerative Colitis & Proctitis. About Ulcerative Colitis & Proctitis

Ulcerative Colitis & Proctitis. About Ulcerative Colitis & Proctitis Ulcerative Colitis & Proctitis About Ulcerative Colitis & Proctitis When you first learn that you have ulcerative colitis, you will probably feel overwhelmed. You may not even have heard of ulcerative

More information

Diagnostic and Treatment Challenges in Inflammatory Bowel Disease. Disclosures

Diagnostic and Treatment Challenges in Inflammatory Bowel Disease. Disclosures Diagnostic and Treatment Challenges in Inflammatory Bowel Disease Joel R. Rosh, MD Director, Pediatric Gastroenterology Goryeb Children's Hospital/Atlantic Health Professor of Pediatrics Icahn School of

More information

How Should a Patient With Known Crohn s Disease and a Flare of Symptoms Be Evaluated?

How Should a Patient With Known Crohn s Disease and a Flare of Symptoms Be Evaluated? How Should a Patient With Known Crohn s Disease and a Flare of Symptoms Be Evaluated? Edward V. Loftus, Jr., M.D. Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic Rochester,

More information

Overlapping IBD and IBS

Overlapping IBD and IBS Overlapping IBD and IBS Meira Abramowitz MD Assistant Clinical Professor of Medicine Jill Roberts Center for Inflammatory Bowel Disease Division of Gastroenterology and Hepatology New York Presbyterian

More information

Crohn s and Colitis Foundation of Canada / Vertex Pharmaceuticals. Sponsored Research Program in Inflammatory Bowel Disease

Crohn s and Colitis Foundation of Canada / Vertex Pharmaceuticals. Sponsored Research Program in Inflammatory Bowel Disease Crohn s and Colitis Foundation of Canada / Vertex Pharmaceuticals Sponsored Research Program in Inflammatory Bowel Disease Presentation Overview Background on inflammatory bowel disease Partner Overview

More information

DIVERTICULAR DISEASE

DIVERTICULAR DISEASE DIVERTICULAR DISEASE Practical Advances in Internal Medicine Symposium April 2016 Evolving concepts We fundamentally know very little about this common diagnosis New insights and questions What causes

More information

PIDS AND GASTROINTESTINAL DISORDERS

PIDS AND GASTROINTESTINAL DISORDERS PRIMARY IMMUNODEFICIENCIES PIDS AND GASTROINTESTINAL DISORDERS PIDS AND GASTROINTESTINAL DISORDERS 1 PRIMARY IMMUNODEFICIENCIES ABBREVIATIONS 6-MP AR AZA CGD 6-mercaptopurine Autosomal recessive Azathioprine

More information

Decision systems in quality registries

Decision systems in quality registries Decision systems in quality registries Stockholm Dec 9 th, 2014 Jonas Halfvarson, MD, PhD Dept of Gastronterology, Faculty of Medicine and Health, Örebro University 1 Quality registries for chronic diseases

More information

Complications that may occur with ulcerative colitis:

Complications that may occur with ulcerative colitis: Ulcerative Colitis What is ulcerative colitis? Ulcerative colitis is one of the major forms of inflammatory bowel disease. The other major form is Crohn s disease. Ulcerative colitis is felt to be due

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Multiple Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Multiple Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Multiple Technology Appraisal Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional

More information

How does the disease activity of Ulcerative Colitis relate to the incidence of Colon cancer? A) Study Purpose and Rationale

How does the disease activity of Ulcerative Colitis relate to the incidence of Colon cancer? A) Study Purpose and Rationale How does the disease activity of Ulcerative Colitis relate to the incidence of Colon cancer? A) Study Purpose and Rationale Ulcerative colitis is a disease of the colon that affects 1:1000 individuals,

More information

Measuring severity of disease and defining treatment benefit using the Simple Endoscopic Activity Score (SES-CD)

Measuring severity of disease and defining treatment benefit using the Simple Endoscopic Activity Score (SES-CD) Measuring severity of disease and defining treatment benefit using the Simple Endoscopic Activity Score (SES-CD) Jean-Frederic COLOMBEL Icahn Medical School at Mount Sinai, New York J-F Colombel has served

More information

Telemedinsk udvikling

Telemedinsk udvikling F A C UL T Y O F HE AL T H A ND ME D I C A L S C I E N C E S U N I V E R S I T Y O F C O P E N H A G E N Telemedinsk udvikling Motivational Interviewing Sygeplejerskens rolle - i centrum af ehealth Fagligt

More information

Inflammatory bowel disease

Inflammatory bowel disease 6 April 2007 gastrointestinal disease 35 Inflammatory bowel disease By Heather Johnson, RGN, inflammatory bowel disease nurse specialist, Department of Gastroenterology, The Royal Bournemouth and Christchurch

More information

What are the Unmet Needs in the Management of IBD?

What are the Unmet Needs in the Management of IBD? 23/6/214 What are the Unmet Needs in the Management of IBD? Shane Devlin, MD, FRCPC Inflammatory Bowel Disease Group The University of Calgary Some Real Cases: #1 32 yo male with pan UC. Grumbling phenotype

More information

Surgical Treatment of Crohn s Disease

Surgical Treatment of Crohn s Disease ENORMOUS TOPIC Surgical Treatment of Crohn s Disease Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco Distribution Gastroduodenal Small bowel Colon Rectum Perianal

More information

Patterns of inflammatory bowel disease in Asians, Africans and Caucasians, any clues to aetiology? Chris Probert

Patterns of inflammatory bowel disease in Asians, Africans and Caucasians, any clues to aetiology? Chris Probert Patterns of inflammatory bowel disease in Asians, Africans and Caucasians, any clues to aetiology? Chris Probert Overview Aetiology of IBD: the current paradigm Genetics of IBD IBD in Asians and Africans

More information

Opportunistic Infections Related to Immune Suppressant and Biologic Drug Therapy in IBD

Opportunistic Infections Related to Immune Suppressant and Biologic Drug Therapy in IBD Opportunistic Infections Related to Immune Suppressant and Biologic Drug Therapy in IBD Raymond Cross, M.D., M.S., AGAF Associate Professor of Medicine Director of the Inflammatory Bowel Disease Program

More information

Focus Biobank Inflammatory Bowel Disease

Focus Biobank Inflammatory Bowel Disease Focus Biobank Inflammatory Bowel Disease University Hospitals Leuven KU Leuven Isabelle Cleynen, PhD Inflammatory Bowel Disease Crohn s disease (CD) Entire GI tract Transmural Fistulas and/or strictures

More information

Choosing Outcome Measures in Pediatric IBD. Anne M Griffiths, MD Hospital for Sick Children University of Toronto Toronto, Canada

Choosing Outcome Measures in Pediatric IBD. Anne M Griffiths, MD Hospital for Sick Children University of Toronto Toronto, Canada Choosing Outcome Measures in Pediatric IBD Anne M Griffiths, MD Hospital for Sick Children University of Toronto Toronto, Canada Disclosures The content of this presentation reflect my personal opinions

More information

Adult Inflammatory Bowel Disease Physician Performance Measures Set. August 2011*

Adult Inflammatory Bowel Disease Physician Performance Measures Set. August 2011* Adult Inflammatory Bowel Disease Physician Performance Measures Set August 2011* *Last revised on October 26, 2011 American Gastroenterological Association Adult Inflammatory Bowel Disease Physician Performance

More information

Crohn s Disease. are at decreased risk for developing Crohn s disease. Crohn s disease may also be called ileitis or enteritis.

Crohn s Disease. are at decreased risk for developing Crohn s disease. Crohn s disease may also be called ileitis or enteritis. Crohn s Disease What is Crohn s disease? Crohn s disease is an ongoing disorder that causes inflammation of the digestive tract, also referred to as the gastrointestinal (GI) tract. Crohn s disease can

More information

Crohn s Disease National Digestive Diseases Information Clearinghouse

Crohn s Disease National Digestive Diseases Information Clearinghouse Crohn s Disease National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH Crohn s disease causes inflammation

More information

Change in Incidence of Crohn s Disease and Ulcerative Colitis in Denmark. A Study Based on the National Registry of Patients, 1981 1992

Change in Incidence of Crohn s Disease and Ulcerative Colitis in Denmark. A Study Based on the National Registry of Patients, 1981 1992 International Journal of Epidemiology International Epidemiological Association 1997 Vol. 26, No. 5 Printed in Great Britain Change in Incidence of Crohn s Disease and Ulcerative Colitis in Denmark. A

More information

Fecal Calprotectin Test

Fecal Calprotectin Test Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: fecal_calprotectin_test 8/2009 11/2015 11/2016 11/2015 Description of Procedure or Service Fecal calprotectin

More information

Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth

Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes Dr. med. Henrik Csaba Horváth Why is risk stratification for colorectal cancer (CRC)

More information

Medical Therapy for IBD

Medical Therapy for IBD CHILDREN S DIGESTIVE HEALTH & NUTRITION FOUNDATION NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION Medical Therapy for IBD I. INTRODUCTION The treatment of Crohn s disease

More information

Ulcerative colitis patients with low grade dysplasia should undergo frequent surveillance colonoscopies

Ulcerative colitis patients with low grade dysplasia should undergo frequent surveillance colonoscopies Ulcerative colitis patients with low grade dysplasia should undergo frequent surveillance colonoscopies David T. Rubin, MD, FACG, AGAF Associate Professor of Medicine Co-Director, Inflammatory Bowel Disease

More information

Briefing Document. Food and Drug Administration. Center for Drug Evaluation and Research

Briefing Document. Food and Drug Administration. Center for Drug Evaluation and Research Briefing Document Food and Drug Administration Center for Drug Evaluation and Research Meeting: Joint Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC) and the Drug Safety and Risk Management

More information

Inflammatory Bowel Disease (IBD) and Ulcerative Colitis

Inflammatory Bowel Disease (IBD) and Ulcerative Colitis Inflammatory Bowel Disease (IBD) and Ulcerative Colitis Here are some words to help you understand this disease. There are pictures on the next page so you can see these parts in a body. Bowels: The bowels

More information

+ REACTIONS. Kantar Health discusses. disease (IBD) market. pharma.

+ REACTIONS. Kantar Health discusses. disease (IBD) market. pharma. REACTIONS the evolving inflammatory bowel disease (IBD) market Kantar Health discusses the increased prevalence of ibd, how it will affect the current and future market, and opportunities for pharma. april

More information

Inflammatory Bowel Disease 2012

Inflammatory Bowel Disease 2012 Inflammatory Bowel Disease 2012 Caren Corrigan, NP C Suburban Gastroenterology Naperville, Illinois Diagnostic Evaluation of Crohn s Disease and Ulcerative Colitis Objectives 1. Describe and differentiate

More information

Diseases of the Colon. Jack Bragg, D.O., F.A.C.O.I.

Diseases of the Colon. Jack Bragg, D.O., F.A.C.O.I. Diseases of the Colon Jack Bragg, D.O., F.A.C.O.I. Inflammatory Bowel Disease ULCERATIVE COLITIS CROHN S DISEASE Transmural Inflammation Mucosal Ulceration in Colon Ileitis Ileocolitis Colitis Inflammatory

More information

CHAPTER 21. CONSTIPATION, DIARRHEA, & IRRITABLE BOWEL, SELF-ASSESSMENT. 1. Which one of the following conditions is associated with constipation?

CHAPTER 21. CONSTIPATION, DIARRHEA, & IRRITABLE BOWEL, SELF-ASSESSMENT. 1. Which one of the following conditions is associated with constipation? CHAPTER 21. CONSTIPATION, DIARRHEA, & IRRITABLE BOWEL, SELF-ASSESSMENT QUESTIONS AND ANSWERS 1. Which one of the following conditions is associated with constipation? A. Hypotension B. Diabetes mellitus

More information

Surgery for Inflammatory Bowel Disease

Surgery for Inflammatory Bowel Disease Surgery for Inflammatory Bowel Disease Emily Finlayson, MD, MS University of California, San Francisco Crohn s and Colitis Foundation November 2, 2014 Surgery in IBD Up to 50% of IBD patients will require

More information

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...

More information

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis ANTIBIOTIC-ASSOCIATED DIARRHEA Disturbance of the normal colonic microflora Leading to alterations in bacterial degradation

More information

Treat to Target in IBD: Which Targets, and Why Does it Matter?

Treat to Target in IBD: Which Targets, and Why Does it Matter? Treat to Target in IBD: Which Targets, and Why Does it Matter? Stephen B. Hanauer, MD Clifford Joseph Barborka Professor of Medicine Northwestern University Feinberg School of Medicine Chicago, IL Disclosures

More information

Abdominal pain. Agnieszka Dobrowolska- Zachwieja, MD, PhD Department of Gastroenterology and Human Nutrition

Abdominal pain. Agnieszka Dobrowolska- Zachwieja, MD, PhD Department of Gastroenterology and Human Nutrition Abdominal pain Agnieszka Dobrowolska- Zachwieja, MD, PhD Department of Gastroenterology and Human Nutrition Most common symptoms of abdominal disease Pain Nausea and/or vomiting Change in bowel movements

More information

Inflammatory Bowel Disease September Dr Tony Smith Gastroenterologist

Inflammatory Bowel Disease September Dr Tony Smith Gastroenterologist Inflammatory Bowel Disease September 2013 Dr Tony Smith Gastroenterologist Your Questions What are Inflammatory Bowel Diseases? What are the causes? What are the symptoms? How is it diagnosed? What treatments

More information

IBD (Inflammatory bowel disease) pathophysiology

IBD (Inflammatory bowel disease) pathophysiology IBD (Inflammatory bowel disease) pathophysiology Prof. Sina Aziz PhD (Paediatrics) KMDC/ASH 1 Contents of this presentation GI anatomy Prevalence of IBD IBD definition layman IBS and IBD Signs and symptoms

More information

Table of Contents. II. Recommendation statements related to the management of ulcerative colitis and relevant comments

Table of Contents. II. Recommendation statements related to the management of ulcerative colitis and relevant comments Table of Contents Preface Toshifumi Hibi (ii) Development of Scientifically Valid and Easy to Use Guidelines for Clinical Management Fumiaki Ueno (iii) I. Outline of the guidelines for the management of

More information

for your IBD Patient

for your IBD Patient 10 Things to do in Clinic for your IBD Patient Sharmeel K. Wasan, MD, FACG Assistant Professor of Medicine Boston University School of Medicine 1. Vaccinate your patient Immunomodulators and biologics

More information

The Burden of Inflammatory Bowel Disease (IBD) in Canada

The Burden of Inflammatory Bowel Disease (IBD) in Canada Final Report and Recommendations The Burden of Inflammatory Bowel Disease (IBD) in Canada Approved by the Board of Directors of the Crohn s and Colitis Foundation of Canada September 13, 2008 Crohn s and

More information

Crohn s Disease. National Digestive Diseases Information Clearinghouse

Crohn s Disease. National Digestive Diseases Information Clearinghouse Crohn s Disease National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH U.S. Department of Health and Human

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE DEVELOPMENT OF NEW MEDICINAL PRODUCTS FOR THE TREATMENT OF ULCERATIVE COLITIS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE DEVELOPMENT OF NEW MEDICINAL PRODUCTS FOR THE TREATMENT OF ULCERATIVE COLITIS European Medicines Agency London, 24 January 2008 Doc. Ref. CHMP/EWP/18463/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE DEVELOPMENT OF NEW MEDICINAL PRODUCTS FOR THE TREATMENT

More information

Optimizing Treatment Strategies in the Management of Inflammatory Bowel Disease ( IBD )

Optimizing Treatment Strategies in the Management of Inflammatory Bowel Disease ( IBD ) Inflammatory Bowel Disease Center Optimizing Treatment Strategies in the Management of Inflammatory Bowel Disease ( IBD ) Russell D. Cohen, M.D. F.A.C.G. A.G.A.F. Professor of Medicine, Pritzker Medical

More information

In vitro co-culture model of the inflamed intestinal mucosa

In vitro co-culture model of the inflamed intestinal mucosa In vitro co-culture model of the inflamed intestinal mucosa Berlin, December 13, 2011 Eva-Maria Collnot, e.collnot@mx.uni-saarland.de Helmholtz Institute for Pharmaceutical Research Saarland Departement

More information

INFLAMMATORY BOWEL DISEASE (IBD) MAKING THE MOST OF THE RELATIONSHIP WITH YOUR GASTROENTEROLOGIST

INFLAMMATORY BOWEL DISEASE (IBD) MAKING THE MOST OF THE RELATIONSHIP WITH YOUR GASTROENTEROLOGIST INFLAMMATORY BOWEL DISEASE (IBD) MAKING THE MOST OF THE RELATIONSHIP WITH YOUR GASTROENTEROLOGIST Why Is Seeing a Gastroenterologist Important? A gastroenterologist: Is the most qualified doctor to diagnose

More information

Chronic abdominal pain of childhood

Chronic abdominal pain of childhood Chronic abdominal pain of childhood Sandra I. Escalera, M.D. ProHealth Physicians Associate Clinical Professor Department of Pediatrics Yale University School of Medicine Objectives Brief overview of approach

More information

Faecal Calprotectin in Inflammatory Bowel Disease

Faecal Calprotectin in Inflammatory Bowel Disease Faecal Calprotectin in Inflammatory Bowel Disease Executive Summary What This paper sets out a proposal for the introduction of a new stool test (faecal calprotectin) with the clinical pathway for the

More information

Infliximab (Remicade) in IBD Patient Information Leaflet

Infliximab (Remicade) in IBD Patient Information Leaflet Infliximab (Remicade) in IBD Patient Information Leaflet General Information Crohn s disease Infliximab (also known as Remicade) has been licensed by The National Institute for Clinical Excellence for

More information

Probiotics for the Treatment of Adult Gastrointestinal Disorders

Probiotics for the Treatment of Adult Gastrointestinal Disorders Probiotics for the Treatment of Adult Gastrointestinal Disorders Darren M. Brenner, M.D. Division of Gastroenterology Northwestern University, Feinberg School of Medicine Chicago, Illinois What are Probiotics?

More information

Crohn's disease and pregnancy.

Crohn's disease and pregnancy. Gut, 1984, 25, 52-56 Crohn's disease and pregnancy. R KHOSLA, C P WILLOUGHBY, AND D P JEWELL From the Gastroenterology Unit, Radcliffe Infirmary, Oxford SUMMARY Infertility and the outcome of pregnancy

More information

Leukapheresis for inflammatory bowel disease

Leukapheresis for inflammatory bowel disease Issue date: June 2005 Leukapheresis for inflammatory bowel disease Understanding NICE guidance information for people considering the procedure, and for the public Information about NICE Interventional

More information

What Is Clostridium Difficile (C. Diff)? CLOSTRIDIUM DIFFICILE (C. DIFF)

What Is Clostridium Difficile (C. Diff)? CLOSTRIDIUM DIFFICILE (C. DIFF) What Is Clostridium Difficile (C. Diff)? Clostridium difficile, or C. diff for short, is an infection from a bacterium, or bug, that can grow in your intestines and cause bad GI symptoms. The main risk

More information

Diverticulosis and Diverticular Disease. Clark Harrison MD Gastroenterology Consultants

Diverticulosis and Diverticular Disease. Clark Harrison MD Gastroenterology Consultants Diverticulosis and Diverticular Disease Clark Harrison MD Gastroenterology Consultants Diverticulosis definitions: Diverticulosis-a sac-like protrusion of the colonic wall. Diverticular disease-clinically

More information

Clostridium Difficile Colitis. Presented by Mark Skains August 2003

Clostridium Difficile Colitis. Presented by Mark Skains August 2003 Clostridium Difficile Colitis Presented by Mark Skains August 2003 What is Clostridium Difficile Gram positive rod Produces spores (hang out in diverticula) Forms Endotoxin A + B which cause diarrhea.

More information

Blau's Disease / Juvenile Sarcoidosis

Blau's Disease / Juvenile Sarcoidosis www.printo.it/pediatric-rheumatology/ie/intro Blau's Disease / Juvenile Sarcoidosis Version of 2016 1. WHAT IS BLAU S DISEASE/JUVENILE SARCOIDOSIS 1.1 What is it? Blau syndrome is a genetic disease. Patients

More information

Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis

Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis Microscopic Colitis: Collagenous Colitis and Lymphocytic Colitis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is

More information

an average period of 16 months, varying from three to 55 months. Pain was rarely severe and was a prominent symptom but it was not possible to

an average period of 16 months, varying from three to 55 months. Pain was rarely severe and was a prominent symptom but it was not possible to Gut, 1970, 11, 1001-1006 Crohn's disease of the stomach and duodenum J. F. FIELDING, D. K. M. TOYE, D. C. BETON, AND W. T. COOKE The Nutritional and Intestinal Unit and the Department of Radiology, The

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections

More information

MODULE 1. Inflammatory Bowel Disease

MODULE 1. Inflammatory Bowel Disease MODULE 1. Inflammatory Bowel Disease Review of the anatomy of the gastrointestinal (GI) tract: The GI tract is comprised of a hollow tube through which food, fluid, and other bowel contents pass. The tube

More information

Research in IBD at University of Colorado Denver

Research in IBD at University of Colorado Denver Research in IBD at University of Colorado Denver Blair Fennimore, MD Assistant Professor of Medicine Division of Gastroenterology and Hepatology UCH Crohn s and Colitis Center Mucosal Inflammation Program

More information

Awareness about Inflammatory Bowel Disease a Survey Based Study

Awareness about Inflammatory Bowel Disease a Survey Based Study British Journal of Research www.britishjr.org Original Article Awareness about Inflammatory Bowel Disease a Survey Based Study Safila Naveed*, Asra Hameed and Wishah Zehra Jaffery Faculty of Pharmacy,

More information

Pediatric Gastroenterology Fellowship Pediatric Nutrition Rotation Goals and Objectives - 1 st Year

Pediatric Gastroenterology Fellowship Pediatric Nutrition Rotation Goals and Objectives - 1 st Year Pediatric Nutrition Rotation Goals and Objectives - 1 st Year Goal 1: Gain experience and competency in managing common and rare gastrointestinal, liver and nutritional problems. (Competencies: patient

More information

Crohn s Disease. National Digestive Diseases Information Clearinghouse

Crohn s Disease. National Digestive Diseases Information Clearinghouse Crohn s Disease National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is Crohn s disease? Crohn s disease is an ongoing disorder

More information

Digestive and Liver Disease

Digestive and Liver Disease Digestive and Liver Disease 43 (2011) 1 20 Contents lists available at ScienceDirect Digestive and Liver Disease journal homepage: www.elsevier.com/locate/dld Progress Report The Italian Society of Gastroenterology

More information

http://www.ncbi.nlm.nih.gov/pubmedhealth/pmh0001295/?report=printable

http://www.ncbi.nlm.nih.gov/pubmedhealth/pmh0001295/?report=printable of 13 Crohn's disease - PubMed Health PubMed Health. A service of the National Library of Medicine, National Institutes of Health. A.D.A.M. Medical Encyclopedia. Atlanta (GA): A.D.A.M.; 2011. Crohn's disease

More information

Patient information regarding care and surgery associated with DIVERTICULITIS

Patient information regarding care and surgery associated with DIVERTICULITIS Patient information regarding care and surgery associated with DIVERTICULITIS by: Robert K. Cleary, M.D., John C. Eggenberger, M.D., Amalia J Stefanou, M.D. location: Michigan Heart & Vascular Institute,

More information

Bile Duct Diseases and Problems

Bile Duct Diseases and Problems Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.

More information

Choosing IBD Care. Treatment Guide Inflammatory Bowel Disease

Choosing IBD Care. Treatment Guide Inflammatory Bowel Disease Treatment Guide Inflammatory Bowel Disease Experts at the Cleveland Clinic s Digestive Disease & Surgery Institute and Cleveland Clinic Children s tailor treatment plans to each patient s needs, taking

More information

Clinical experience of natalizumab in Crohn s disease patients in a restricted distribution program

Clinical experience of natalizumab in Crohn s disease patients in a restricted distribution program Original article Annals of Gastroenterology (2013) 26, 1-6 Clinical experience of natalizumab in Crohn s disease patients in a restricted distribution program Chien-Huan Chen a, Gowri Kularatna a, Christian

More information

Colonoscopy Data Collection Form

Colonoscopy Data Collection Form Identifier: Sociodemographic Information Type: Zip Code: Gender: Height: (inches) Race: Ethnicity Inpatient Outpatient Male Female Birth Date: Weight: (pounds) American Indian (Native American) or Alaska

More information

Should we Screen for Celiac Disease in IBS?

Should we Screen for Celiac Disease in IBS? Should we Screen for Celiac Disease in? Brennan Spiegel, MD, MSHS Existential Question: What Is? Dietary factors High sorbitol diet High-fiber diet FODMAP Diet Caffeine Alcohol Infection SIBO C. diff Giardiasis

More information

Colocutaneous Fistula. Disclosures

Colocutaneous Fistula. Disclosures Colocutaneous Fistula Madhulika G. Varma MD Associate Professor Chief, Colorectal Surgery University of California, San Francisco Honoraria Applied Medical Covidien Disclosures 1 Colocutaneous Fistula

More information

THE IMPACT OF INFLAMMATORY BOWEL DISEASE IN CANADA 2012 Final Report and Recommendations

THE IMPACT OF INFLAMMATORY BOWEL DISEASE IN CANADA 2012 Final Report and Recommendations THE IMPACT OF INFLAMMATORY BOWEL DISEASE IN CANADA 2012 Final Report and Recommendations 1 mission Find the cure. vision The Crohn s and Colitis Foundation of Canada (CCFC) believes that a cure will be

More information

Bleeding in the Digestive Tract

Bleeding in the Digestive Tract Bleeding in the Digestive Tract Bleeding in the digestive tract is a symptom of a disease rather than a disease itself. Bleeding can occur as the result of a number of different conditions, some of which

More information

Surgery Grand Rounds. Reoperative Surgery. Crohn s Disease. H. David Vargas, MD, FACS, FASCRS Associate Professor of Surgery

Surgery Grand Rounds. Reoperative Surgery. Crohn s Disease. H. David Vargas, MD, FACS, FASCRS Associate Professor of Surgery Surgery Grand Rounds Reoperative Surgery Crohn s Disease H. David Vargas, MD, FACS, FASCRS Associate Professor of Surgery Department of Surgery University of Kentucky Pathology-Macro Crohn s Disease Chronic

More information

Reliable Non-invasive Discrimination between IBD and IBS

Reliable Non-invasive Discrimination between IBD and IBS Reliable Non-invasive Discrimination between IBD and IBS Whether you need to test one or one hundred samples, trust our experience in Calprotectin Assays to help you find the way. Calprotectin: the Protein

More information

A Case of Complicated Diverticulitis. Brian Clair 8/25/08

A Case of Complicated Diverticulitis. Brian Clair 8/25/08 A Case of Complicated Diverticulitis Brian Clair 8/25/08 Agenda 1. Introduction to Our Patient 2. Diverticulitis -Review of Diverticular Disease -Pathogenesis of Diverticulitis -Radiologic Findings -Treatment

More information